Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Apr'17
Jan'17
Oct'16
Jul'16
Apr'16
Jan'16
Oct'15
Net Sales
97.90
141.52
125.18
97.02
105.14
162.47
141.97
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
97.90
141.52
125.18
97.02
105.14
162.47
141.97
Raw Material Cost
54.46
78.27
67.99
54.02
55.88
87.50
78.44
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
50.97
61.50
54.16
52.34
53.96
69.34
58.66
Other Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure (Excl Depreciation)
105.42
139.77
122.15
106.36
109.84
156.84
137.10
Operating Profit (PBDIT) excl Other Income
-7.5
1.7999999999999998
3
-9.3
-4.699999999999999
5.6000000000000005
4.9
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Operating Profit (PBDIT)
-7.53
1.76
3.04
-9.34
-4.70
5.63
4.88
Interest
2.12
1.91
1.85
1.67
1.71
1.89
1.85
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
43.44
63.26
57.20
43.00
49.26
74.97
63.53
Depreciation
1.53
2.01
2.07
2.02
2.51
2.83
2.75
Profit Before Tax
-9.65
-7.10
0.69
-11.02
-6.41
2.71
3.03
Tax
0.00
-0.20
0.00
0.00
0.00
0.45
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-9.65
-6.90
0.69
-11.02
-6.41
2.26
3.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-9.65
-6.90
0.69
-11.02
-6.41
2.26
3.03
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-9.65
-6.90
0.69
-11.02
-6.41
2.26
3.03
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
50.81
60.42
67.29
66.59
77.60
83.98
81.63
Earnings per share (EPS)
-0.62
-0.45
0.04
-0.71
-0.41
0.15
0.2
Diluted Earnings per share
-0.62
-0.45
0.04
-0.71
-0.41
0.15
0.2
Operating Profit Margin (Excl OI)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Gross Profit Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
PAT Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Apr 2017 is -6.85% vs -18.02% in Apr 2016
Consolidate Net Profit
YoY Growth in quarter ended Apr 2017 is -51.56% vs -3,100.00% in Apr 2016
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Apr 2017 is -59.57% vs -393.75% in Apr 2016
Interest
YoY Growth in quarter ended Apr 2017 is 23.53% vs 0.00% in Apr 2016
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Apr 2017 has improved from Apr 2016
Compare Quarterly Results Of CytoMed Therapeutics Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
97.90
0.00
97.90
Other Operating Income
0.00
0.00
0.00
Total Operating income
97.90
0.00
97.90
Raw Material Cost
54.46
0.06
54.40
90,666.67%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0
0.00
0.00
Selling and Distribution Expenses
50.97
2.44
48.53
1,988.93%
Other Expenses
0.00
1.15
-1.15
-100.00%
Total Expenditure (Excl Depreciation)
105.42
13.98
91.44
654.08%
Operating Profit (PBDIT) excl Other Income
-7.53
-13.98
6.45
46.14%
Other Income
0.00
7.25
-7.25
-100.00%
Operating Profit (PBDIT)
-7.53
-6.67
-0.86
-12.89%
Interest
2.12
0.00
2.12
Exceptional Items
0
0.00
0.00
Gross Profit (PBDT)
43.44
-0.06
43.50
72,500.00%
Depreciation
1.53
0.06
1.47
2,450.00%
Profit Before Tax
-9.65
-6.73
-2.92
-43.39%
Tax
0.00
0.00
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
-9.65
-6.73
-2.92
-43.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-9.65
-6.73
-2.92
-43.39%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-9.65
-6.73
-2.92
-43.39%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
50.81
7.03
43.78
622.76%
Earnings per share (EPS)
-0.62
-0.11
-0.51
-463.64%
Diluted Earnings per share
-0.62
-0.11
-0.51
-463.64%
Operating Profit Margin (Excl OI)
0%
0.00%
0.00
0.00%
Gross Profit Margin
0%
0.00%
0.00
0.00%
PAT Margin
0%
0.00%
0.00
0.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 9.79 Million
in Apr 2017Figures in Million
QoQ Growth in quarter ended Apr 2017 is -30.81% vs 13.02% in Jan 2017
YoY Growth in quarter ended Apr 2017 is -6.85% vs -18.02% in Apr 2016
Quarterly - Consolidate Net Profit
Consolidate Net Profit -0.97 Million
in Apr 2017Figures in Million
QoQ Growth in quarter ended Apr 2017 is -40.58% vs -1,085.71% in Jan 2017
YoY Growth in quarter ended Apr 2017 is -51.56% vs -3,100.00% in Apr 2016
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.75 Million
in Apr 2017Figures in Million
QoQ Growth in quarter ended Apr 2017 is -516.67% vs -40.00% in Jan 2017
YoY Growth in quarter ended Apr 2017 is -59.57% vs -393.75% in Apr 2016
Quarterly - Interest
Interest 0.21 Million
in Apr 2017Figures in Million
QoQ Growth in quarter ended Apr 2017 is 10.53% vs 5.56% in Jan 2017
YoY Growth in quarter ended Apr 2017 is 23.53% vs 0.00% in Apr 2016
Quarterly - Operating Profit Margin (Excl OI)
No Operating Profit Margin (Excl OI) in the last few periods
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
